BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) Financials

$16.97

$0.03 (0.18%)

As on 04-Sep-2026 16:00EDT

Market cap

$1,059 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

6.6

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	24.07	8.19	-25.97	59.66	5.24	113.72
Cost of Revenue	0.00	-8.46	--	--	--	--
Gross Profit	24.07	28.87	-25.97	6.40	5.24	--
Operating Expenses	0.62	0.39	-25.97	6.35	5.17	0.49
Operating Profit (EBIT)	0.93	8.46	1.54	0.05	0.07	--
Other Income	--	--	--	--	--	--
Profit before Tax	23.45	20.02	-26.47	59.12	79.56	113.23
Provision for Tax	--	--	--	0.01	--	--
Profit after Tax (Net Income)	23.45	20.02	-26.47	59.12	79.56	113.23
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	768.57	588.14	600.20	625.77	3,023.74	1,635.97
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.03	7.97	5.70	10.56	--	--
Current Liabilities	--	--	--	12.48	8.62	1.52
Total Liabilities	774.59	596.10	606.13	648.81	554.55	1,729.46

Assets ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	773.33	594.40	606.13	648.81	-2,514.83	1,719.63
Current Assets	26.56	-0.04	0.00	0.00	0.41	1.08
Total Assets	774.59	596.10	606.13	648.81	554.55	1,729.46
Total Debt*	0.28	0.06	0.68	0.21	0.10	--
Net Current Assets	--	--	--	--	--	--

Cashflow ($ Mln)	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	65.52	32.02	-0.87	-21.56	107.17	-1,515.00
Cash Flow from Investing Activities	--	--	--	-0.04	-0.97	--
Cash from Financing Activities	-65.52	-32.02	0.88	21.34	-96.98	1,524.16
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	1.77	1.44	--	--	--	--
Cash EPS ($)	1.77	1.44	--	--	--	--
Adjusted Book Value ($)	57.98	42.18	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	4.94	2.30	--	--	--	--
Free Cash Flow per Share ($)	4.94	2.30	--	--	--	--

Profitability Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	3.46	3.37	-4.32	3.24	3.41	--
ROE (%)	3.46	3.37	-4.32	3.24	3.41	--
ROA (%)	3.42	3.33	-4.22	9.83	6.97	--
EBIT Margin (%)	101.50	268.87	102.81	99.18	--	--
Net Margin (%)	97.44	244.30	101.93	99.09	1,517.89	99.57
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	1.94	1.32	-1.44	10.38	-0.95	--
EBIT Growth (%)	10.90	182.51	-145.12	--	--	--
Net Profit Growth (%)	17.17	175.62	-144.78	-25.69	-29.74	--
EPS Growth (%)	0.23	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	8.14	10.21	--	--	--	--
Price / Book Value	0.25	0.35	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	177.53	10.20	--	--	--	--
Close Price ($)	14.40	14.65	15.43	25.36	28.65	--
High Price ($)	16.57	17.05	25.78	30.94	30.96	--
Low Price ($)	14.27	12.93	14.33	22.60	12.60	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	0.00	0.00	0.00	0.00	0.00	--
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	--
Current Ratio	--	--	--	0.00	0.05	0.71
Quick Ratio	--	--	--	--	--	--
Interest Coverage	313,228.00	400,548.64	--	--	--	--

Operating Efficiency Ratios	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	4.97	19.24	-9.12	5.33	7.17	0.51
Asset Turnover	0.04	0.01	-0.04	0.10	0.00	--
Receivable days	21.03	87.93	-39.00	10.88	33.10	1.84
Inventory Days	--	--	--	--	--	--
Payable days	--	-10.06	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--